Resources and support

1. Matos Casano HA, Anjum F. Six-Minute Walk Test. Statpearls NCBI Bookshelf. www.ncbi.nlm.nih.gov/books/NBK576420/. Updated August 14, 2023. Accessed November 16, 2023. 2. de Baptista C, Vicente AM, Souza MA, Cardoso J, Ramalho VM, Mattiello-Sverzut AC. Methods of 10-Meter Walk Test and Repercussions for Reliability Obtained in Typically Developing Children. Rehabil Res Pract. US National Library of Medicine. 20 Aug. 2020. www.ncbi.nlm.nih.gov/pmc/articles/PMC7455832/. Accessed November 16, 2023. 3. Vectors 101. ASGCT - American Society of Gene & Cell Therapy. patienteducation.asgct.org. https://patienteducation.asgct.org/gene-therapy-101/vectors-101. Accessed August 1, 2023. 4. Cleveland Clinic medical. Amino Acid: Benefits & Food Sources. Cleveland Clinic. my.clevelandclinic.org/health/articles/22243-amino-acids. Accessed August 1, 2023. 5. Merriam-Webster. www.merriam-webster.com/dictionary/. Accessed August 1, 2023. 6. Johns Hopkins Medicine. Muscle biopsy. 14 Aug. 2019. www.hopkinsmedicine.org/health/treatment-tests-and-therapies/muscle-biopsy#:~:text=What. Accessed August 1, 2023. 7. MedLinePlus. Creatine Kinase: Medlineplus Medical Test. U.S. National Library of Medicine. medlineplus.gov/lab-tests/creatine-kinase/. Accessed August 1, 2023. 8. Timonen A, et al. Duchenne Muscular Dystrophy Newborn Screening: Evaluation of a New GSP^® Neonatal Creatine Kinase-MM Kit in a US and Danish Population. Int J Neonatal Screen. 2019 Sep; 5(3): 27. doi:10.3390/ijns5030027. Accessed August 1, 2023. 9. Types of Mutations - Parent Project Muscular Dystrophy. Parent Project Muscular Dystrophy, 2017. www.parentprojectmd.org/about-duchenne/what-is-duchenne/types-of-mutations/. Accessed August 1, 2023. 10. Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. Duchenne muscular dystrophy. Nat Rev Dis Primers. 2021:7(1):13. doi:10.1038/s41572-021-00248-3. Accessed August 1, 2023. 11. National Human Genome Research Institute. Gene. Genome.gov. Published 2020. Updated November 2023. https://www.genome.gov/genetics-glossary/Gene. Accessed November 9, 2023. 12. What Are Genetic Therapies? National Heart Lung and Blood Institute. U.S. Department of Health and Human Services. www.nhlbi.nih.gov/health/genetic-therapies. Accessed August 1, 2023. 13. Food and Drug Administration. What is gene therapy? FDA. Published July 25, 2018. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/what-gene-therapy. Accessed August 1, 2023. 14. Gowers’ Sign. www.ncbi.nlm.nih.gov/books/NBK540973/. Accessed August 1, 2023. 15. Birnkrant DJ, Bushby K, Bann CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17(3):251- 267. doi:https://doi.org/10.1016/s1474-4422(18)30024-3. Accessed August 1, 2023. 16. Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Disc. 2019;18(5):358-378. doi:https://doi.org/10.1038/s41573-019-0012-9. Accessed August 1, 2023. 17. North Star Ambulatory Assessment (NSAA). https://www.musculardystrophyuk.org/static/s3fs-public/2021-08/NSAA%20_Manual_%2015102020.pdf?VersionId=BaPGDWk5TxA3rtF2DDipAVYlOJ5Eoumo. Accessed August 1, 2023. 18. National Human Genome Research Institute. Nucleus. Genome.gov. Published 2020. https://www.genome.gov/genetics-glossary/Nucleus. Accessed August 1, 2023. 19. Mazzone ES, Coratti G, Sormani MP, et al. Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study. PLoS One. 2016;11(3):e0151445. Published 2016 Mar 16. doi:10.1371/journal.pone.0151445. Accessed November 16, 2023. 20. Ryffel GU. Transgene flow: facts, speculations and possible countermeasures. GM Crops Food. 2014;5(4):249-258. doi:10.4161/21645698.2014.945883. Accessed August 1, 2023.